Alzheimer's Patient Groups Pressure US to Pay for Biogen Drug
Patient groups are mounting a public pressure campaign aimed at persuading the U.S. government to loosen proposed restrictions on new Alzheimer’s treatments, spending millions of dollars on television and local advertisements that began running during…